Treatment of neovascular age-related macular degeneration with anti-vascular endothelial growth factor drugs: progress from mechanisms to clinical applications

被引:1
|
作者
Cheng, Shizhou [1 ]
Zhang, Shu [1 ]
Huang, Mingyan [1 ]
Liu, Yuxuan [1 ]
Zou, Xunyu [1 ]
Chen, Xiaoming [1 ]
Zhang, Zuhai [1 ]
机构
[1] Yangtze Univ, Dept Ophthalmol, Affiliated Hosp 1, Jingzhou, Peoples R China
关键词
neovascular age-related macular degeneration; vascular endothelial growth factor; treatment; mechanism; clinical application; INTRAVITREAL AFLIBERCEPT INJECTION; RANIBIZUMAB; THERAPY; VEGF; ANGIOGENESIS; OUTCOMES; PHARMACOKINETICS; CLASSIFICATION; DISCOVERY; HISTORY;
D O I
10.3389/fmed.2024.1411278
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Neovascular age-related macular degeneration (nARMD) is an important cause of visual impairment and blindness in the elderly, with choroidal neovascularization in the macula as the main pathological feature. The onset of nARMD is closely related to factors including age, oxidative stress, and lipid metabolism. Vascular endothelial growth factor (VEGF) is an important factor contributing to nARMD as well as choroidal neovascularization and retinal leakage formation. At present, anti-VEGF therapy is the only treatment that improves vision and halts disease progression in most patients, making anti-VEGF drugs a landmark development for nARMD treatment. Although intravitreal injection of anti-VEGF drugs has become the first-line treatment for nARMD, this treatment has many shortcomings including repeated injections, poor or no response in some patients, and complications such as retinal fibrosis. As a result, several new anti-VEGF drugs are being developed. This review provides a discussion of these new anti-VEGF drugs for the treatment of nARMD.
引用
收藏
页数:11
相关论文
共 50 条
  • [1] Influence of Vitreomacular Adhesion on Anti-Vascular Endothelial Growth Factor Treatment for Neovascular Age-Related Macular Degeneration
    Moreira Kanadani, Tereza Cristina
    dos Reis Veloso, Carlos Eduardo
    Dorairaj, Syril
    Nehemy, Marcio Bittar
    OPHTHALMIC RESEARCH, 2017, 58 (01) : 18 - 26
  • [2] Anti-vascular endothelial growth factor for neovascular age-related macular degeneration
    Solomon, Sharon D.
    Lindsley, Kristina
    Vedula, Satyanarayana S.
    Krzystolik, Magdalena G.
    Hawkins, Barbara S.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2019, (03):
  • [3] Anti-vascular endothelial growth factor for neovascular age-related macular degeneration
    Solomon, Sharon D.
    Lindsley, Kristina
    Vedula, Satyanarayana S.
    Krzystolik, Magdalena G.
    Hawkins, Barbara S.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2014, (08):
  • [4] Disparities in access to anti-vascular endothelial growth factor treatment for neovascular age-related macular degeneration
    Finger, Robert P.
    Xie, Jing
    Fotis, Kathy
    Parikh, Sumit
    Cummins, Rob
    Mitchell, Paul
    Guymer, Robyn H.
    CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2017, 45 (02) : 143 - 151
  • [5] Patterns of anti-vascular endothelial growth factor discontinuation in neovascular age-related macular degeneration
    Basilious, Amy
    Smuck, Bobbi
    Duncan, Julie
    Malvankar-Mehta, Monali S.
    Juncal, Verena R.
    Hooper, Phil
    Sheidow, Tom G.
    CANADIAN JOURNAL OF OPHTHALMOLOGY-JOURNAL CANADIEN D OPHTALMOLOGIE, 2024, 59 (02): : e161 - e169
  • [6] Anti-Vascular Endothelial Growth Factor (VEGF) Treatment of Age-Related Macular Degeneration
    Bolling, James P.
    CURRENT DRUG THERAPY, 2012, 7 (02) : 90 - 95
  • [7] Molecular Biomarkers of Neovascular Age-Related Macular Degeneration With Incomplete Response to Anti-Vascular Endothelial Growth Factor Treatment
    Mantel, Irmela
    Borgo, Angelica
    Guidotti, Jacopo
    Forestier, Edwige
    Kirsch, Olga
    Derradji, Yasmine
    Waridel, Patrice
    Burdet, Frederic
    Mehl, Florence
    Schweizer, Claude
    Roduit, Raphael
    FRONTIERS IN PHARMACOLOGY, 2020, 11
  • [8] Development of Intraretinal Fluid in Neovascular Age-Related Macular Degeneration During Anti-Vascular Endothelial Growth Factor Treatment
    Cho, Han Joo
    Yoon, Wontae
    Yoon, Jihyun
    Na, Seung Kwan
    Lee, Jihyun
    Kim, Jaemin
    Kim, Chul Gu
    Kim, Jong Woo
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2022, 234 : 6 - 14
  • [9] Patterns of treatment discontinuation in patients receiving anti-vascular endothelial growth factor for neovascular age-related macular degeneration
    Dhingra, Narendra
    Upasani, Deepa
    Ghanchi, Faruque
    INDIAN JOURNAL OF OPHTHALMOLOGY, 2022, 70 (06) : 2065 - 2070
  • [10] Twenty Years of Anti-Vascular Endothelial Growth Factor Therapeutics in Neovascular Age-Related Macular Degeneration Treatment
    Moon, Bo-Hyun
    Kim, Younghwa
    Kim, Soo-Young
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (16)